Old Republic International (ORI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Virtual meeting format increased shareholder participation compared to prior in-person meetings.
Meeting agenda and rules were made available on the web portal at the start.
Key officers, directors, and KPMG audit partners were introduced at the outset.
Board and executive committee updates
Nearly all continuing directors attended the meeting virtually, with only one absent.
Spencer LeRoy III and Craig Smiddy were designated as board representatives for the meeting.
Corporate governance
Shareholder list was available for inspection 10 days prior to the meeting.
Todd Gray and Victoria Poole were appointed as inspectors of elections.
Board refreshment initiative aims to rebalance director classes within the next year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Old Republic International
- Net income rose 35% to $330M, with strong premium growth and higher book value per share.ORI
Q1 20261 May 2026 - Q4 net income surged, but operating EPS fell; premiums, book value, and capital returns rose.ORI
Q4 202515 Apr 2026 - Shareholders will vote virtually on directors, auditor ratification, and executive pay, focusing on governance and ESG.ORI
Proxy filing31 Mar 2026 - Q2 operating income and premiums rose, led by General Insurance; $479M returned to shareholders.ORI
Q2 20242 Feb 2026 - Net income and book value rose sharply on premium growth, investment gains, and capital returns.ORI
Q3 202418 Jan 2026 - Strong operating income, premium growth, and $2.00 special dividend drove record returns.ORI
Q4 20249 Jan 2026 - Net operating income and premiums grew, with EPS up 21% and book value per share up 7.2%.ORI
Q1 202527 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ORI
Proxy Filing1 Dec 2025 - Q3 2025 delivered 8.1% premium growth, 18.5% book value gain, and a major specialty acquisition.ORI
Q3 202531 Oct 2025